Bustamante, Regine Fher S.
HRN: 21-22-80 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2024
CEFUROXIME 750MG (VIAL)
04/08/2024
04/14/2024
IVTT
310mg
Q8h
UTI
Checking Final Appropriateness
04/11/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
04/11/2024
04/18/2024
ORAL
1mL
Q4H
Oral Thrush
Checking Final Appropriateness